Skip to main content

CytomX Therapeutics, Inc. (NASDAQ: CTMX) Investor Securities Class Action Lawsuit 05/21/2020

  • If you purchased shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 13, 2020 - The case was voluntarily dismissed. May 21, 2020 - An investor in shares of CytomX Therapeutics, Inc. (NASDAQ: CTMX) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by CytomX Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between May 17...



You must register (for free) or login to view the entire case.